Published January, 2015
By Keith C. Ferdinand
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

---

Published November, 2014
By Edgar V. Lerma and Matthew R. Weir
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

The treatment of hypertension has become the most important intervention in the management of all forms of chronic kidney disease. Chronic Kidney Disease and Hypertension is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease.

---

Published December, 2012
By Philip B. Gorelick and Venkatesh Aiyagari
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

In addition to prescriptive measures for first stroke prevention, the book illuminates current regimens for care immediately after acute stroke and for the prevention of recurrent stroke.

---

Published November, 2010
By George L. Bakris and Dennis G. Caralis
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug eluting stents for peripheral arterial disease.

---

Published November, 2010
By George A. Mansoor
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

Secondary forms of hypertension are not uncommon in clinical prac tice, but they are often overlooked or forgotten by clinicians in many fields of medicine.

---

Published November, 2010
By L. Michael Prisant
Publisher: Springer (Humana Press Inc.)
Series: Clinical Hypertension and Vascular Diseases
Rating:
Availability: Available

The authors examine in detail the mechanisms of hypertension in the elderly, the lifestyle trials and outcomes trials that were conducted in older persons, as well as the problems of clinical evaluation, secondary hypertension, adherence, and target organ damage.

---